Facebook's move comes after a series of measures taken by the tech firm to remove problematic content that it had previously been hesitant to take down. Additionally, the company's stance to delete false claims came after major pharmaceutical firms like Pfizer and AstraZeneca filed for emergency use authorisations for their COVID-19 vaccines and after the UK became the first country to approve one of the frontrunners.
"This could include false claims about the safety, efficacy, ingredients or side effects of the vaccines. For example, we will remove false claims that COVID-19 vaccines contain microchips, or anything else that isn't on the official vaccine ingredient list," Facebook added.
Facebook has been following the policy to remove false claims about coronavirus that could lead to "imminent physical harm," such as posts promoting false cures and fake conspiracy theories linking the virus to 5G. The company, as a result of this policy, removed 12 million posts between March and October. The company, so far, had only removed posts containing misinformation about vaccines in Pakistan and Samoa.
The social media platform added, "We will also remove conspiracy theories about COVID-19 vaccines that we know today are false: like specific populations are being used without their consent to test the vaccine's safety."
Facebook CEO Mark Zuckerberg, On Monday, said the social media giant would show its users "authoritative information about the vaccines," without explaining how it plans to distribute this information.
Tackling misinformation about the COVID-19 vaccines would prove difficult for social media platforms as governments globally look to start immunising people against the disease.
Even Google's video-sharing service YouTube and Chinese social media app TikTok have said that they will remove false claims about such vaccines. Twitter, however, says it's still working through its plans.
Also Read: What an irony! Mainland China beats US to be India's biggest trade partner in H1FY21
Also Read: This stock fell over 13% in two sessions after Serum Institute cut stake
Also Read: HDFC Bank needs to strengthen IT systems before expanding further: RBI chief Das